Literature DB >> 26477022

Spectrum of cerebral spinal fluid findings in patients with posterior reversible encephalopathy syndrome.

Lars Neeb, Jenneke Hoekstra, Matthias Endres, Bob Siegerink, Eberhard Siebert, Thomas G Liman.   

Abstract

The purpose of this study is to characterize the spectrum of cerebrospinal fluid (CSF) findings in patients with posterior reversible encephalopathy syndrome (PRES)and determine its associations with severity of edema. In this retrospective cross-sectional study electronic medical reports were screened for patients with PRES. Clinical and laboratory data closest to onset of clinical symptoms were collected. Neuroimaging reports from all patients were categorized according to the presence of vasogenic edema,cytotoxic edema and contrast enhancement. From Jan 1999to Feb 2015, 87 patients with PRES and CSF findings were included. Mean total protein levels were 793 ± 929 mg/l. Median cell counts were 2/μl (IQR 1-4). Eight patients had cell counts[6/μl with a maximum of 41/μl. In 31 patients with extended CSF analysis, mean CSF/serum albuminquotient (QAlb) was 10.1 (IQR 6-17.3). An elevated QAlb (age-adjusted) was found in 74 % of these 31 patients. PRES patients with severe edema had higher mean total protein levels in CSF (mean difference = 407 mg/l; 95 %CI 187-628). Significant correlations were found for edema severity with levels of CSF protein (r = 0.48, p<0.001) as well with QAlb (r = 0.44, p = 0.013). This study shows that total protein in CSF and QAlb are elevated and correlate with severity of edema in PRES patients, whereas pleocytosis was rare in our cohort. This supports the theory that PRES is caused by a dysfunctional blood brain barrier.

Entities:  

Mesh:

Year:  2016        PMID: 26477022     DOI: 10.1007/s00415-015-7928-8

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  16 in total

Review 1.  Cerebrospinal fluid analysis: disease-related data patterns and evaluation programs.

Authors:  H Reiber; J B Peter
Journal:  J Neurol Sci       Date:  2001-03-01       Impact factor: 3.181

Review 2.  Posterior reversible encephalopathy syndrome, part 2: controversies surrounding pathophysiology of vasogenic edema.

Authors:  W S Bartynski
Journal:  AJNR Am J Neuroradiol       Date:  2008-04-10       Impact factor: 3.825

Review 3.  Posterior reversible encephalopathy syndrome--Insight into pathogenesis, clinical variants and treatment approaches.

Authors:  Guido Granata; Antonio Greco; Giannicola Iannella; Massimo Granata; Alessandra Manno; Ersilia Savastano; Giuseppe Magliulo
Journal:  Autoimmun Rev       Date:  2015-05-18       Impact factor: 9.754

4.  Guidelines on routine cerebrospinal fluid analysis. Report from an EFNS task force.

Authors:  F Deisenhammer; A Bartos; R Egg; N E Gilhus; G Giovannoni; S Rauer; F Sellebjerg
Journal:  Eur J Neurol       Date:  2006-09       Impact factor: 6.089

5.  Clinical and radiological differences in posterior reversible encephalopathy syndrome between patients with preeclampsia-eclampsia and other predisposing diseases.

Authors:  T G Liman; G Bohner; P U Heuschmann; M Scheel; M Endres; E Siebert
Journal:  Eur J Neurol       Date:  2012-01-17       Impact factor: 6.089

6.  Posterior reversible encephalopathy syndrome: the endothelial hypotheses.

Authors:  A Marra; M Vargas; P Striano; L Del Guercio; P Buonanno; G Servillo
Journal:  Med Hypotheses       Date:  2014-03-01       Impact factor: 1.538

7.  The clinical and radiological spectrum of posterior reversible encephalopathy syndrome: the retrospective Berlin PRES study.

Authors:  T G Liman; G Bohner; P U Heuschmann; M Endres; E Siebert
Journal:  J Neurol       Date:  2011-06-30       Impact factor: 4.849

8.  Delayed CSF enhancement in posterior reversible encephalopathy syndrome.

Authors:  B E Hamilton; G M Nesbit
Journal:  AJNR Am J Neuroradiol       Date:  2008-01-09       Impact factor: 3.825

9.  Determinants of recovery from severe posterior reversible encephalopathy syndrome.

Authors:  Stephane Legriel; Olivier Schraub; Elie Azoulay; Philippe Hantson; Eric Magalhaes; Isaline Coquet; Cedric Bretonniere; Olivier Gilhodes; Nadia Anguel; Bruno Megarbane; Laurent Benayoun; David Schnell; Gaetan Plantefeve; Julien Charpentier; Laurent Argaud; Bruno Mourvillier; Arnaud Galbois; Ludivine Chalumeau-Lemoine; Michel Rivoal; François Durand; Arnaud Geffroy; Marc Simon; Annabelle Stoclin; Jean-Louis Pallot; Charlotte Arbelot; Martine Nyunga; Olivier Lesieur; Gilles Troché; Fabrice Bruneel; Yves-Sébastien Cordoliani; Jean-Pierre Bedos; Fernando Pico
Journal:  PLoS One       Date:  2012-09-14       Impact factor: 3.240

10.  Posterior reversible encephalopathy syndrome mimicking a left middle cerebral artery stroke.

Authors:  Santo Terranova; Jai Dev Kumar; Richard B Libman
Journal:  Open Neuroimag J       Date:  2012-02-03
View more
  11 in total

1.  Authors' Reply to Drs Bourque and Breiner, Re: Cerebrospinal Fluid in Posterior Reversible Encephalopathy Syndrome.

Authors:  Colin A Ellis; Ramani Balu
Journal:  Neurohospitalist       Date:  2019-06-12

Review 2.  Anti-Angiogenic Tyrosine Kinase Inhibitors and Reversible Posterior Leukoencephalopathy Syndrome: Could Hypomagnesaemia Be the Trigger?

Authors:  Rashmi R Shah
Journal:  Drug Saf       Date:  2017-05       Impact factor: 5.606

3.  Factors associated with fatal outcome in posterior reversible encephalopathy syndrome: a retrospective analysis of the Berlin PRES study.

Authors:  Eberhard Siebert; G Bohner; T Liebig; M Endres; T G Liman
Journal:  J Neurol       Date:  2016-11-04       Impact factor: 4.849

4.  Serum Neurofilament Light: a Potential Diagnostic and Prognostic Biomarker in Obstetric Posterior Reversible Encephalopathy Syndrome.

Authors:  Xiaobo Fang; Yanling Liang; Weixi Zhang; Qiong Wang; Jingsi Chen; Jia Chen; Yongqiang Lin; Yanli Chen; Li Yu; Haibin Wang; Dunjin Chen
Journal:  Mol Neurobiol       Date:  2021-09-22       Impact factor: 5.590

5.  Acute disseminated encephalomyelitis following endonasal resection of a craniopharyngioma: illustrative case.

Authors:  Konrad Gag; Jonas Müller; Marie Süße; Robert Fleischmann; Henry W S Schroeder
Journal:  J Neurosurg Case Lessons       Date:  2021-10-18

6.  Cerebrospinal Fluid in Posterior Reversible Encephalopathy Syndrome: Implications of Elevated Protein and Pleocytosis.

Authors:  Colin A Ellis; Andrew C McClelland; Suyash Mohan; Emory Kuo; Scott E Kasner; Cen Zhang; Pouya Khankhanian; Ramani Balu
Journal:  Neurohospitalist       Date:  2018-09-27

7.  Dengue-Associated Posterior Reversible Encephalopathy Syndrome, Vietnam.

Authors:  Nguyen Thi Hoang Mai; Nguyen Hoan Phu; Ho Dang Trung Nghia; Tran My Phuong; Du Trong Duc; Nguyen Van Vinh Chau; Bridget Wills; Choie Cheio Tchoyoson Lim; Guy Thwaites; Cameron Paul Simmons; Sophie Yacoub
Journal:  Emerg Infect Dis       Date:  2018-02       Impact factor: 6.883

Review 8.  Posterior reversible encephalopathy syndrome.

Authors:  Marlene Fischer; Erich Schmutzhard
Journal:  J Neurol       Date:  2017-01-04       Impact factor: 4.849

9.  Central-Variant Posterior Reversible Encephalopathy Syndrome with Albuminocytologic Dissociation.

Authors:  Sang-Woo Lee; Seung-Jae Lee
Journal:  Case Rep Neurol       Date:  2018-02-02

10.  The Innate Immune Response Characterizes Posterior Reversible Encephalopathy Syndrome.

Authors:  Christopher Nelke; Andreas Schulte-Mecklenbeck; Marc Pawlitzki; Leoni Rolfes; Saskia Räuber; Catharina C Gross; Jens Minnerup; Sven G Meuth; Heinz Wiendl; Tobias Ruck
Journal:  J Clin Immunol       Date:  2021-04-12       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.